2021 annual financial data
Niki BioSolutions 2021 Operating margin
Direct answer
Operating margin was -1,245.59%.
Operating income was -19,207,000 USD and net income was -25,048,000 USD.
Operating cash flow was -14,651,633 USD.
Get free Niki BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,542,000 USD
- Operating income
- -19,207,000 USD
- Net income
- -25,048,000 USD
- Operating cash flow
- -14,651,633 USD